Kalvista Pharmaceuticals, Inc.盘中异动大幅拉升5.11%

市场透视06-24

北京时间2025年06月24日22时59分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价急速上涨5.11%。截至发稿，该股报12.54美元/股，成交量24.1338万股，换手率0.49%，振幅5.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.51百万美元，每股收益-0.92美元，毛利-229000.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2545239358?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-24 22:59","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2545239358","market":"us","top_or_hot":-1,"title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.11%","media":"市场透视","content":"<div>\n<p>北京时间2025年06月24日22时59分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价急速上涨5.11%。截至发稿，该股报12.54美元/股，成交量24.1338万股，换手率0.49%，振幅5.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.51百万美元，每股收益-0.92美元，毛利-229000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624225949a4bbb46a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-24 22:59 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624225949a4bbb46a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月24日22时59分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价急速上涨5.11%。截至发稿，该股报12.54美元/股，成交量24.1338万股，换手率0.49%，振幅5.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.51百万美元，每股收益-0.92美元，毛利-229000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624225949a4bbb46a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KALV","symbol_name":"Kalvista Pharmaceuticals Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624225949a4bbb46a&s=b","article_id":"2545239358","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624225949a4bbb46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545239358","pubTimestamp":1750777189,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月24日22时59分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.11%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大，Nucana Plc、Adial Pharmaceuticals, Inc、Ibio, Inc.较为活跃，换手率分别为828.74%、520.69%、390.01%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Eyenovia, Inc.，振幅分别为176.26%、69.60%、59.85%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KALV":"Kalvista Pharmaceuticals Inc","BK4139":"生物科技"},"translate_title":"Kalvista Pharmaceuticals, Inc. jumped 5.11% after intraday movement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KALV":0.9},"content_text":"北京时间2025年06月24日22时59分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价急速上涨5.11%。截至发稿，该股报12.54美元/股，成交量24.1338万股，换手率0.49%，振幅5.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.51百万美元，每股收益-0.92美元，毛利-229000.00美元，市盈率-3.32倍。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、Eyenovia, Inc.涨幅较大，Nucana Plc、Adial Pharmaceuticals, Inc、Ibio, Inc.较为活跃，换手率分别为828.74%、520.69%、390.01%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Eyenovia, Inc.，振幅分别为176.26%、69.60%、59.85%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。该公司的产品组合包括针对遗传性血管性水肿和糖尿病性黄斑水肿的小分子血浆钾化酶抑制剂;口服血浆钾激肽抑制剂。从地理上讲，该公司的业务遍及整个美国地区。该公司还在进行一种新型口服XIIa因子抑制剂项目的临床前开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2545239358","isCrawlerRequest":true}

Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.11%

精彩评论

Kalvista Pharmaceuticals, Inc.盘中异动大幅拉升5.11%